nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new formulation of praziquantel to achieve schistosomiasis elimination
|
Yang, Guo-Jing |
|
|
23 |
7 |
p. 774-776 |
artikel |
2 |
A new network for pathogen surveillance
|
Burki, Talha |
|
|
23 |
7 |
p. 792-793 |
artikel |
3 |
An exciting time for antifungal therapy
|
The Lancet Infectious Diseases, |
|
|
23 |
7 |
p. 763 |
artikel |
4 |
Balancing adjunctive therapy for tuberculosis treatment
|
Ndjeka, Norbert |
|
|
23 |
7 |
p. 771-772 |
artikel |
5 |
Brazil tackles its tuberculosis burden
|
Bagcchi, Sanjeet |
|
|
23 |
7 |
p. 790 |
artikel |
6 |
Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better?
|
Torreele, Els |
|
|
23 |
7 |
p. e253-e258 |
artikel |
7 |
Can a single dose of Modified Vaccinia Ankara-Bavarian Nordic vaccine protect against mpox?
|
Ogoina, Dimie |
|
|
23 |
7 |
p. 768-769 |
artikel |
8 |
Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis
|
Garcia-Prats, Anthony J |
|
|
23 |
7 |
p. 778-780 |
artikel |
9 |
Correction to Lancet Infect Dis 2023; published online May 4. https://doi.org/10.1016/S1473-3099(23)00121-4
|
|
|
|
23 |
7 |
p. e227 |
artikel |
10 |
Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic review
|
Rice, Stephen |
|
|
23 |
7 |
p. e228-e239 |
artikel |
11 |
Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system
|
Lewnard, Joseph A |
|
|
23 |
7 |
p. 806-815 |
artikel |
12 |
Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: an observational study
|
Bertran, Marta |
|
|
23 |
7 |
p. 828-835 |
artikel |
13 |
Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial
|
N'Goran, Eliézer K |
|
|
23 |
7 |
p. 867-876 |
artikel |
14 |
Engaging pharmacists and medicine vendors in antimicrobial stewardship in LMICs
|
Oga-Omenka, Charity |
|
|
23 |
7 |
p. 786-787 |
artikel |
15 |
Highly multidrug-resistant Gram-negative bacterial infections in war victims in Ukraine, 2022
|
Ljungquist, Oskar |
|
|
23 |
7 |
p. 784-786 |
artikel |
16 |
How to survive to the COVID-19 pandemic
|
Bisbas, Georgia |
|
|
23 |
7 |
p. 797 |
artikel |
17 |
Imprinted hybrid immunity against XBB reinfection
|
Boyton, Rosemary J |
|
|
23 |
7 |
p. 764-765 |
artikel |
18 |
Infectious disease surveillance update
|
Zwizwai, Ruth |
|
|
23 |
7 |
p. 793 |
artikel |
19 |
James Banta
|
Bagcchi, Sanjeet |
|
|
23 |
7 |
p. 795 |
artikel |
20 |
James Ward—tackling STIs in Indigenous Australians
|
Kirby, Tony |
|
|
23 |
7 |
p. 796 |
artikel |
21 |
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study
|
Chemaitelly, Hiam |
|
|
23 |
7 |
p. 816-827 |
artikel |
22 |
Maintaining a robust pipeline of antibiotics
|
Jesudason, Timothy |
|
|
23 |
7 |
p. 791 |
artikel |
23 |
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection
|
Carr, Edward J |
|
|
23 |
7 |
p. 781-784 |
artikel |
24 |
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
|
Wilkins, Deidre |
|
|
23 |
7 |
p. 856-866 |
artikel |
25 |
Nirsevimab-resistant respiratory syncytial virus strains are rare but there
|
Peeples, Mark E |
|
|
23 |
7 |
p. 773-774 |
artikel |
26 |
Participatory research for improving Inuit health
|
Venkatesan, Priya |
|
|
23 |
7 |
p. 788 |
artikel |
27 |
Prevention of long COVID: progress and challenges
|
Al-Aly, Ziyad |
|
|
23 |
7 |
p. 776-777 |
artikel |
28 |
Prevention of non-ventilator-associated hospital-acquired pneumonia in Switzerland: a type 2 hybrid effectiveness–implementation trial
|
Wolfensberger, Aline |
|
|
23 |
7 |
p. 836-846 |
artikel |
29 |
Progress in preventing non-ventilator-associated hospital-acquired pneumonia
|
Klompas, Michael |
|
|
23 |
7 |
p. 769-771 |
artikel |
30 |
Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study
|
Tan, Celine Y |
|
|
23 |
7 |
p. 799-805 |
artikel |
31 |
Real-world use of nirmatrelvir–ritonavir: who benefits?
|
Molina, Kyle C |
|
|
23 |
7 |
p. 765-767 |
artikel |
32 |
Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
|
Gonzales-Luna, Anne J |
|
|
23 |
7 |
p. e259-e265 |
artikel |
33 |
Research in brief
|
Devi, Sharmila |
|
|
23 |
7 |
p. 794 |
artikel |
34 |
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial
|
Cross, Gail B |
|
|
23 |
7 |
p. 847-855 |
artikel |
35 |
Serpiginous-like choroiditis in ocular tuberculosis
|
Tyagi, Mudit |
|
|
23 |
7 |
p. 877 |
artikel |
36 |
Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs
|
Rigby, Ishmeala |
|
|
23 |
7 |
p. e240-e252 |
artikel |
37 |
Statin use in people living with HIV
|
Venkatesan, Priya |
|
|
23 |
7 |
p. 789 |
artikel |
38 |
The dangers of using large language models for peer review
|
Donker, Tjibbe |
|
|
23 |
7 |
p. 781 |
artikel |
39 |
The ups and downs of observational vaccine research
|
Barda, Noam |
|
|
23 |
7 |
p. 767-768 |
artikel |
40 |
Tracheobronchial tuberculosis and its sequelae in children and adolescents
|
Yang, Ming-Jin |
|
|
23 |
7 |
p. 786 |
artikel |
41 |
Trichophyton rubrum-induced Majocchi's granuloma in an immunocompromised patient
|
Vetsiou, Evangelia |
|
|
23 |
7 |
p. 878 |
artikel |
42 |
“West” vs “Rest”—Epidemic Orientalism
|
Sherwood-Martin, Hollie |
|
|
23 |
7 |
p. 798 |
artikel |